AnalystsJoseph SchwartzJoseph Schwartz's Stock Forecasts
AnalystsJoseph Schwartz
Sectors:
Industries:
Analyst Ranking
Top 29%
#1572 out of 5548 analysts
Average Return
+1.59%
Win Rate
36%56 out of 154
Risk vs Reward
Poor
Good
Joseph Schwartz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | +328.57% | $10.57 | $45.30 | 2025-02-25 - 2026-02-24 | Buy |
Proqr Therapeutics NvPRQR | +259.62% | $5.20 | $18.70 | 2017-09-26 - 2018-09-26 | Buy |
Arena Pharmaceuticals IncARNA | +242.33% | $13.30 | $45.53 | 2017-05-19 - 2018-05-18 | Buy |
Inflarx NvIFRX | +235.62% | $1.46 | $4.90 | 2022-05-12 - 2023-05-11 | Buy |
Enliven Therapeutics IncELVN | +232.66% | $6.40 | $21.29 | 2022-03-16 - 2023-03-15 | Buy |
Joseph Schwartz Analyst Color
Get additional color on Joseph Schwartz's coverage of popular stocks
Joseph Schwartz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eloxx Pharmaceuticals IncELOX | 1 | Buy | $32.00 | +150.00% | Initiates Coverage On | a month ago |
Larimar Therapeutics IncLRMR | 1 | Buy | $13.00 | +453.19% | Assumes | a month ago |
Pharvaris NvPHVS | 6 | Buy | $65.00 | +106.94% | Maintains | 2 months ago |
Gossamer Bio IncGOSS | 9 | Buy | $80.00 | +732.90% | Upgrades | 3 months ago |
Irulya Therapeutics IncIRLA | 1 | Buy | $80.00 | +141.84% | Initiates Coverage On | 4 months ago |
Uniqure NvQURE | 5 | Buy | $70.00 | +212.08% | Maintains | 4 months ago |
Fulcrum Therapeutics IncFULC | 4 | Hold | $4.00 | +8.70% | Downgrades | 5 months ago |
Atrium Therapeutics IncRNA | 1 | Buy | $25.00 | +204.88% | Initiates Coverage On | 5 months ago |
An2 Therapeutics IncANTX | 4 | Buy | $9.00 | +153.52% | Upgrades | 5 months ago |
Satellos Bioscience IncMSLE | 1 | Buy | $20.00 | +211.53% | Initiates Coverage On | 7 months ago |
Insmed IncINSM | 5 | Buy | $215.00 | +130.22% | Maintains | 7 months ago |
Ultragenyx Pharmaceutical IncRARE | 6 | Buy | $70.00 | +347.28% | Maintains | 10 months ago |
Amicus Therapeutics IncFOLD | 8 | Hold | $14.50 | +0.07% | Downgrades | 10 months ago |
Applied Therapeutics IncAPLT | 3 | Hold | $1.00 | +870.87% | Downgrades | a year ago |
Spruce Biosciences IncSPRB | 7 | Buy | $160.00 | +254.37% | Upgrades | a year ago |
Design Therapeutics IncDSGN | 5 | Buy | $14.00 | +36.72% | Upgrades | a year ago |
Inflarx NvIFRX | 4 | Hold | $2.00 | +28.21% | Downgrades | a year ago |
Biomarin Pharmaceutical IncBMRN | 9 | Hold | $60.00 | +7.24% | Downgrades | a year ago |
Aurinia Pharmaceuticals IncAUPH | 6 | Hold | $16.00 | -5.10% | Downgrades | a year ago |
Monopar TherapeuticsMNPR | 1 | Buy | $115.00 | +62.77% | Initiates Coverage On | a year ago |
Avidity Biosciences IncRNAM | 4 | Hold | $72.00 | +388.14% | Downgrades | a year ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Buy | $88.00 | N/A | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 8 | Hold | $15.00 | N/A | Maintains | a year ago |
Kalvista Pharmaceuticals IncKALV | 6 | Buy | $20.00 | N/A | Maintains | a year ago |
Regulus Therapeutics IncRGLS | 3 | Hold | $7.00 | N/A | Downgrades | a year ago |
Maze Therapeutics IncMAZE | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
Travere Therapeutics IncTVTX | 6 | Buy | $40.00 | N/A | Maintains | 2 years ago |
Solid Biosciences IncSLDB | 5 | Buy | $12.00 | N/A | Upgrades | 2 years ago |
Mereo Biopharma Group PLCMREO | 2 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Synlogic IncSYBX | 4 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Onkure Therapeutics IncOKUR | 3 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Cartesian Therapeutics IncRNAC | 2 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Reata Pharmaceuticals IncRETA | 3 | Buy | $115.00 | N/A | Upgrades | 3 years ago |
Ptc Therapeutics IncPTCT | 1 | Hold | $48.00 | N/A | Initiates Coverage On | 4 years ago |
Ionis Pharmaceuticals IncIONS | 1 | Hold | $34.00 | N/A | Maintains | 4 years ago |
Ascendis Pharma AASND | 14 | Buy | $163.00 | N/A | Maintains | 4 years ago |
Applied Molecular Transport IncAMTI | 6 | Hold | $2.00 | N/A | Downgrades | 4 years ago |
Pepgen IncPEPG | 2 | Buy | $33.00 | N/A | Maintains | 4 years ago |
Chemocentryx IncCCXI1 | 3 | Hold | $52.00 | N/A | Downgrades | 4 years ago |
Edgewise Therapeutics IncEWTX | 2 | Buy | $30.00 | N/A | Maintains | 4 years ago |
Protagonist Therapeutics IncPTGX | 5 | Buy | $30.00 | N/A | Maintains | 4 years ago |
Enliven Therapeutics IncELVN | 4 | Buy | $31.00 | N/A | Maintains | 5 years ago |
Arena Pharmaceuticals IncARNA | 6 | Hold | $100.00 | N/A | Downgrades | 5 years ago |
Spark Therapeutics IncONCE | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 9 years ago |
Proqr Therapeutics NvPRQR | 1 | Buy | $12.00 | N/A | Maintains | 9 years ago |
Clementia Pharmaceuticals IncCMTA | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 9 years ago |
Achillion Pharmaceuticals IncACHN | 1 | Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.